vedolizumab
Ligand Summary
a humanized monoclonal antibody that targets the 4beta7 integrin exclusively, and modulates inflammation in the gastrointestinal tract
ChEMBL: CHEMBL1743087
DrugCentral: 4982
LyCHI: vedolizumab
Target Activities
ITGA4
Integrin alpha-4
1 Activities
Items per page:
1 – 1 of 1
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
IC50 | 8.3 | ANTIBODY BINDING | ||||
ITGB7
Integrin beta-7
1 Activities
Items per page:
1 – 1 of 1
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
IC50 | 8.3 | ANTIBODY BINDING | ||||